FindTrial
Sign In

EGFR-TKI versus chemotherapy for Asians with previously untreated advanced non-small cell lung cancer: a meta-analysis

EGFR-TKI versus chemotherapy for Asians with previously untreated advanced non-small cell lung cancer: a meta-analysis - EGFR-TKIs versus chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000028424
Enrollment
1000
Registered
2017-07-31
Start date
2017-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EGFR mutation-positive previously untreated non-small cell lung cancer

Interventions

None listed

Sponsors

Division of Respiratory Medicine and Allergology, Department of Medicine, Showa University, Hatanodai, 1-5-8, Shinagawa-ku, Tokyo, 142-8666, Japan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a meta-analysis of phase 3 randomized trials or their follow up analyses.

Exclusion criteria

Exclusion criteria: case-control, cohort, and non-blind clinical trials

Design outcomes

Primary

MeasureTime frame
Overall survival—

Secondary

MeasureTime frame
progression free survival—

Countries

Japan

Contacts

Public ContactKoichi Ando

Showa University Division of Respiratory Medicine and Allergology, Department of Medicine

koichi-a@med.showa-u.ac.jp+81-3-3784-8532

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026